Adiponectin levels are inversely related to insulin resistance and are lower in obese subjects and patients with established insulin resistance, e.g., in type 2 diabetes, NAFLD/NASH and hypertension. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatohepatitis.